Use of Micro Bioreactor systems to streamline cell line evaluation and upstream process development for monoclonal antibody production
BMC Proc
.
2011 Nov 22;5 Suppl 8(Suppl 8):P14.
doi: 10.1186/1753-6561-5-S8-P14.
eCollection 2011.
Authors
Steve R C Warr
1
,
Jai Patel
1
,
Rongzan Ho
1
,
Katy V Newell
1
Affiliation
1
GlaxoSmithKline, Stevenage, Hertfordshire, SG1 2NY, UK.
PMID:
22373478
PMCID:
PMC3284950
DOI:
10.1186/1753-6561-5-S8-P14
No abstract available